Načítá se...
Serum Levels of CA19‐9 in patients with nonmalignant respiratory diseases
CA19‐9 is a specific tumor marker in patients with gastrointestinal cancer; however, some patients with respiratory disease can have elevated serum levels of CA19‐9 as well. In this study we evaluated serum CA19‐9 levels of patients with nonmalignant respiratory diseases. We also estimated the progn...
Uloženo v:
| Vydáno v: | J Clin Lab Anal |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Subscription Services, Inc., A Wiley Company
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6648978/ https://ncbi.nlm.nih.gov/pubmed/17385665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.20136 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|